Comprehensive Stock Comparison
Compare ReposiTrak, Inc. (TRAK) vs Salesforce, Inc. (CRM) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | TRAK | 10.5% revenue growth vs CRM's 9.6% |
| Value | CRM | Lower P/E (16.5x vs 23.8x) |
| Quality / Margins | TRAK | 30.9% net margin vs CRM's 18.0% |
| Stability / Safety | TRAK | Beta 0.80 vs CRM's 1.04, lower leverage |
| Dividends | TRAK | 1.0% yield, vs CRM's 0.9% |
| Momentum (1Y) | CRM | -34.0% vs TRAK's -55.3% |
| Efficiency (ROA) | TRAK | 12.9% ROA vs CRM's 6.6%, ROIC 21.4% vs 10.9% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Valuation efficiency (growth/$)
Defensive / Recession hedge
Business Model
What each company does and how it makes money
ReposiTrak is a software-as-a-service provider offering supply chain compliance and food safety solutions for the grocery and retail industries. It generates revenue primarily through SaaS subscriptions for its compliance tracking, supplier management, and B2B e-commerce platforms — with additional income from professional consulting services. The company's competitive advantage lies in its specialized focus on food safety regulatory compliance, creating a sticky ecosystem where both retailers and their suppliers must use its platform to meet stringent industry requirements.
Salesforce is a cloud-based customer relationship management (CRM) software company that helps businesses manage sales, service, marketing, and commerce operations. It generates revenue primarily through subscription fees for its SaaS platform—with sales cloud (~30%), service cloud (~25%), and platform/other (~45%) being its main segments. Its competitive moat lies in its massive ecosystem of integrated applications, enterprise data architecture, and high switching costs for customers deeply embedded in its platform.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
CRM leads in 1 of 6 categories (Valuation Metrics). TRAK leads in 1 (Profitability & Efficiency). 4 tied.
Financial Metrics (TTM)
CRM is the larger business by revenue, generating $41.5B annually — 1766.8x TRAK's $24M. TRAK is the more profitable business, keeping 30.9% of every revenue dollar as net income compared to CRM's 18.0%. On growth, CRM holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | TRAKReposiTrak, Inc. | CRMSalesforce, Inc. |
|---|---|---|
| RevenueTrailing 12 months | $24M | $41.5B |
| EBITDAEarnings before interest/tax | $8M | $11.4B |
| Net IncomeAfter-tax profit | $7M | $7.5B |
| Free Cash FlowCash after capex | $7M | $14.4B |
| Gross MarginGross profit ÷ Revenue | +85.0% | +77.7% |
| Operating MarginEBIT ÷ Revenue | +30.2% | +21.5% |
| Net MarginNet income ÷ Revenue | +30.9% | +18.0% |
| FCF MarginFCF ÷ Revenue | +29.1% | +34.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.7% | +12.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +13.2% | +18.3% |
Valuation Metrics
At 24.9x trailing earnings, TRAK trades at a 0% valuation discount to CRM's 25.0x P/E. Adjusting for growth (PEG ratio), TRAK offers better value at 0.73x vs CRM's 2.04x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | TRAKReposiTrak, Inc. | CRMSalesforce, Inc. |
|---|---|---|
| Market CapShares × price | $158M | $187.4B |
| Enterprise ValueMkt cap + debt − cash | $130M | $186.8B |
| Trailing P/EPrice ÷ TTM EPS | 24.86x | 24.97x |
| Forward P/EPrice ÷ next-FY EPS est. | 23.84x | 16.54x |
| PEG RatioP/E ÷ EPS growth rate | 0.73x | 2.04x |
| EV / EBITDAEnterprise value multiple | 17.43x | 20.95x |
| Price / SalesMarket cap ÷ Revenue | 7.01x | 4.51x |
| Price / BookPrice ÷ Book value/share | 3.36x | 3.15x |
| Price / FCFMarket cap ÷ FCF | 18.85x | 13.01x |
Profitability & Efficiency
TRAK delivers a 14.6% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $13 for CRM. TRAK carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to CRM's 0.11x. On the Piotroski fundamental quality scale (0–9), CRM scores 8/9 vs TRAK's 7/9, reflecting strong financial health.
| Metric | TRAKReposiTrak, Inc. | CRMSalesforce, Inc. |
|---|---|---|
| ROE (TTM)Return on equity | +14.6% | +12.6% |
| ROA (TTM)Return on assets | +12.9% | +6.6% |
| ROICReturn on invested capital | +21.4% | +10.9% |
| ROCEReturn on capital employed | +12.9% | +11.9% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 8 |
| Debt / EquityFinancial leverage | 0.01x | 0.11x |
| Net DebtTotal debt minus cash | -$28M | -$590M |
| Cash & Equiv.Liquid assets | $29M | $7.3B |
| Total DebtShort + long-term debt | $509,973 | $6.7B |
| Interest CoverageEBIT ÷ Interest expense | 165.50x | 44.14x |
Total Returns (with DRIP)
A $10,000 investment in TRAK five years ago would be worth $14,138 today (with dividends reinvested), compared to $9,104 for CRM. Over the past 12 months, CRM leads with a -34.0% total return vs TRAK's -55.3%. The 3-year compound annual growth rate (CAGR) favors TRAK at 13.4% vs CRM's 6.6% — a key indicator of consistent wealth creation.
| Metric | TRAKReposiTrak, Inc. | CRMSalesforce, Inc. |
|---|---|---|
| YTD ReturnYear-to-date | -26.5% | -23.2% |
| 1-Year ReturnPast 12 months | -55.3% | -34.0% |
| 3-Year ReturnCumulative with dividends | +45.8% | +21.1% |
| 5-Year ReturnCumulative with dividends | +41.4% | -9.0% |
| 10-Year ReturnCumulative with dividends | -1.8% | +192.3% |
| CAGR (3Y)Annualised 3-year return | +13.4% | +6.6% |
Risk & Volatility
TRAK is the less volatile stock with a 0.80 beta — it tends to amplify market swings less than CRM's 1.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CRM currently trades 64.3% from its 52-week high vs TRAK's 36.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | TRAKReposiTrak, Inc. | CRMSalesforce, Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.80x | 1.04x |
| 52-Week HighHighest price in past year | $23.72 | $303.07 |
| 52-Week LowLowest price in past year | $8.11 | $174.57 |
| % of 52W HighCurrent price vs 52-week peak | +36.7% | +64.3% |
| RSI (14)Momentum oscillator 0–100 | 31.1 | 47.5 |
| Avg Volume (50D)Average daily shares traded | 78K | 8.6M |
Analyst Outlook
Wall Street rates TRAK as "Buy" and CRM as "Buy". Consensus price targets imply 175.9% upside for TRAK (target: $24) vs 53.5% for CRM (target: $299). For income investors, TRAK offers the higher dividend yield at 0.99% vs CRM's 0.85%.
| Metric | TRAKReposiTrak, Inc. | CRMSalesforce, Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $24.00 | $299.00 |
| # AnalystsCovering analysts | 1 | 97 |
| Dividend YieldAnnual dividend ÷ price | +1.0% | +0.9% |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | $0.09 | $1.66 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.0% | +6.7% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Mar 20 | Feb 26 | Change |
|---|---|---|---|
| ReposiTrak, Inc. (TRAK) | 100 | 218.44 | +118.4% |
| Salesforce, Inc. (CRM) | 100 | 124.47 | +24.5% |
ReposiTrak, Inc. (TRAK) returned +41% over 5 years vs Salesforce, Inc. (CRM)'s -9%. A $10,000 investment in TRAK 5 years ago would be worth $14,138 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2017 | 2026 | Change |
|---|---|---|---|
| ReposiTrak, Inc. (TRAK) | $19M | $23M | +19.4% |
| Salesforce, Inc. (CRM) | $8.4B | $41.5B | +394.8% |
Salesforce, Inc.'s revenue grew from $8.4B (2017) to $41.5B (2026) — a 19.4% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2017 | 2026 | Change |
|---|---|---|---|
| ReposiTrak, Inc. (TRAK) | 19.9% | 30.9% | +54.8% |
| Salesforce, Inc. (CRM) | 3.8% | 18.0% | +366.6% |
Salesforce, Inc.'s net margin went from 4% (2017) to 18% (2026).
Chart 4P/E Ratio History — 10 Years
| Stock | 2017 | 2026 | Change |
|---|---|---|---|
| ReposiTrak, Inc. (TRAK) | 50.3 | 35.3 | -29.8% |
| Salesforce, Inc. (CRM) | 393.2 | 25 | -93.6% |
ReposiTrak, Inc. has traded in a 27x–76x P/E range over 9 years; current trailing P/E is ~25x. Salesforce, Inc. has traded in a 25x–393x P/E range over 7 years; current trailing P/E is ~25x.
Chart 5EPS Growth — 10 Years
| Stock | 2017 | 2026 | Change |
|---|---|---|---|
| ReposiTrak, Inc. (TRAK) | 0.19 | 0.35 | +84.2% |
| Salesforce, Inc. (CRM) | 0.26 | 7.8 | +2900.0% |
Salesforce, Inc.'s EPS grew from $0.26 (2017) to $7.80 (2026) — a 46% CAGR.
Chart 6Free Cash Flow — 5 Years
ReposiTrak, Inc. generated $8M FCF in 2025 (+65% vs 2021). Salesforce, Inc. generated $14B FCF in 2026 (+252% vs 2021).
TRAK vs CRM: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is TRAK or CRM a better buy right now?
ReposiTrak, Inc. (TRAK) offers the better valuation at 24.9x trailing P/E (23.8x forward), making it the more compelling value choice. Analysts rate ReposiTrak, Inc. (TRAK) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TRAK or CRM?
On trailing P/E, ReposiTrak, Inc. (TRAK) is the cheapest at 24.9x versus Salesforce, Inc. at 25.0x. On forward P/E, Salesforce, Inc. is actually cheaper at 16.5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ReposiTrak, Inc. wins at 0.70x versus Salesforce, Inc.'s 1.35x — a PEG below 1.0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — TRAK or CRM?
Over the past 5 years, ReposiTrak, Inc. (TRAK) delivered a total return of +41.4%, compared to -9.0% for Salesforce, Inc. (CRM). A $10,000 investment in TRAK five years ago would be worth approximately $14K today (assuming dividends reinvested). Over 10 years, the gap is even starker: CRM returned +192.3% versus TRAK's -1.8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TRAK or CRM?
By beta (market sensitivity over 5 years), ReposiTrak, Inc. (TRAK) is the lower-risk stock at 0.80β versus Salesforce, Inc.'s 1.04β — meaning CRM is approximately 30% more volatile than TRAK relative to the S&P 500. On balance sheet safety, ReposiTrak, Inc. (TRAK) carries a lower debt/equity ratio of 1% versus 11% for Salesforce, Inc. — giving it more financial flexibility in a downturn.
05Which has better profit margins — TRAK or CRM?
ReposiTrak, Inc. (TRAK) is the more profitable company, earning 30.9% net margin versus 18.0% for Salesforce, Inc. — meaning it keeps 30.9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TRAK leads at 27.5% versus 21.5% for CRM. At the gross margin level — before operating expenses — TRAK leads at 83.7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is TRAK or CRM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential. By this metric, ReposiTrak, Inc. (TRAK) is the more undervalued stock at a PEG of 0.70x versus Salesforce, Inc.'s 1.35x. A PEG below 1.0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Salesforce, Inc. (CRM) trades at 16.5x forward P/E versus 23.8x for ReposiTrak, Inc. — 7.3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TRAK: 175.9% to $24.00.
07Which pays a better dividend — TRAK or CRM?
All stocks in this comparison pay dividends. ReposiTrak, Inc. (TRAK) offers the highest yield at 1.0%, versus 0.9% for Salesforce, Inc. (CRM).
08Is TRAK or CRM better for a retirement portfolio?
For long-horizon retirement investors, ReposiTrak, Inc. (TRAK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.80), 1.0% yield). Both have compounded well over 10 years (TRAK: -1.8%, CRM: +192.3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between TRAK and CRM?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.